Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.
PDF (1.2M)
+3 authors
Journal: 1993/April - Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
PUBMED: 7681602
Abstract:
A Na(+)- and Cl(-)-coupled serotonin (5-hydroxytryptamine, 5HT) transporter is expressed on human neuronal, platelet, placental, and pulmonary membranes. The brain 5HT transporter appears to be a principal site of action of therapeutic antidepressants and may mediate behavioral and/or toxic effects of cocaine and amphetamines. Oligonucleotides derived from consensus transporter sequences were used to identify human placental cDNAs highly related to the rat brain 5HT carrier. Transfection of one of these cDNAs into HeLa cells yields a high-affinity (Km = 463 nM), Na(+)- and Cl(-)-dependent 5HT transport activity which can be blocked by selective 5HT transport inhibitors, including paroxetine, fluoxetine, and imipramine, and which is antagonized by cocaine and amphetamine. Sequence analysis reveals a 630-amino acid open reading frame bearing 92% identity to the cloned rat brain 5HT transporter, with identical predicted topological features and conserved sites for posttranslational modifications. Unlike the rodent, where a single mRNA appears to encode 5HT transporters, multiple hybridizing RNAs are observed in human placenta and lung. Somatic cell hybrid and in situ hybridization studies are consistent, however, with a single gene encoding the human 5HT transporter, localized to chromosome 17q11.1-17q12.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(169)
References
(39)
Drugs
(3)
Chemicals
(11)
Genes
(1)
Organisms
(1)
Processes
(4)
Anatomy
(7)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Proc Natl Acad Sci U S A 90(6): 2542-2546
PMID: 7681602

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Abstract

A Na(+)- and Cl(-)-coupled serotonin (5-hydroxytryptamine, 5HT) transporter is expressed on human neuronal, platelet, placental, and pulmonary membranes. The brain 5HT transporter appears to be a principal site of action of therapeutic antidepressants and may mediate behavioral and/or toxic effects of cocaine and amphetamines. Oligonucleotides derived from consensus transporter sequences were used to identify human placental cDNAs highly related to the rat brain 5HT carrier. Transfection of one of these cDNAs into HeLa cells yields a high-affinity (Km = 463 nM), Na(+)- and Cl(-)-dependent 5HT transport activity which can be blocked by selective 5HT transport inhibitors, including paroxetine, fluoxetine, and imipramine, and which is antagonized by cocaine and amphetamine. Sequence analysis reveals a 630-amino acid open reading frame bearing 92% identity to the cloned rat brain 5HT transporter, with identical predicted topological features and conserved sites for posttranslational modifications. Unlike the rodent, where a single mRNA appears to encode 5HT transporters, multiple hybridizing RNAs are observed in human placenta and lung. Somatic cell hybrid and in situ hybridization studies are consistent, however, with a single gene encoding the human 5HT transporter, localized to chromosome 17q11.1-17q12.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 2542
2542
icon of scanned page 2543
2543
icon of scanned page 2544
2544
icon of scanned page 2545
2545
icon of scanned page 2546
2546

Images in this article

Fig. 4
Fig. 4
on p.2545
Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ross SB, Renyl AL. Accumulation of tritiated 5-hydroxytryptamine in brain slices. Life Sci. 1967 Jul 1;6(13):1407–1415. [PubMed] [Google Scholar]
  • Kuhar MJ, Roth RH, Aghajanian GK. Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J Pharmacol Exp Ther. 1972 Apr;181(1):36–45. [PubMed] [Google Scholar]
  • O'Reilly CA, Reith ME. Uptake of [3H]serotonin into plasma membrane vesicles from mouse cerebral cortex. J Biol Chem. 1988 May 5;263(13):6115–6121. [PubMed] [Google Scholar]
  • Marcusson JO, Ross SB. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology (Berl) 1990;102(2):145–155. [PubMed] [Google Scholar]
  • Marcusson JO, Andersson A, Bäckström I. Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain. Psychopharmacology (Berl) 1989;99(1):17–21. [PubMed] [Google Scholar]
  • Graham D, Esnaud H, Habert E, Langer SZ. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter. Biochem Pharmacol. 1989 Nov 1;38(21):3819–3826. [PubMed] [Google Scholar]
  • Blakely RD, Berson HE, Fremeau RT, Jr, Caron MG, Peek MM, Prince HK, Bradley CC. Cloning and expression of a functional serotonin transporter from rat brain. Nature. 1991 Nov 7;354(6348):66–70. [PubMed] [Google Scholar]
  • Hoffman BJ, Mezey E, Brownstein MJ. Cloning of a serotonin transporter affected by antidepressants. Science. 1991 Oct 25;254(5031):579–580. [PubMed] [Google Scholar]
  • Rudnick G. Active transport of 5-hydroxytryptamine by plasma membrane vesicles isolated from human blood platelets. J Biol Chem. 1977 Apr 10;252(7):2170–2174. [PubMed] [Google Scholar]
  • Balkovetz DF, Tiruppathi C, Leibach FH, Mahesh VB, Ganapathy V. Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J Biol Chem. 1989 Feb 5;264(4):2195–2198. [PubMed] [Google Scholar]
  • Lee SL, Fanburg BL. Serotonin uptake by bovine pulmonary artery endothelial cells in culture. I. Characterization. Am J Physiol. 1986 May;250(5 Pt 1):C761–C765. [PubMed] [Google Scholar]
  • Rudnick G, Nelson PJ. Platelet 5-hydroxytryptamine transport, an electroneutral mechanism coupled to potassium. Biochemistry. 1978 Oct 31;17(22):4739–4742. [PubMed] [Google Scholar]
  • Humphreys CJ, Levin J, Rudnick G. Antidepressant binding to the porcine and human platelet serotonin transporters. Mol Pharmacol. 1988 Jun;33(6):657–663. [PubMed] [Google Scholar]
  • Reith ME, Zimanyi I, O'Reilly CA. Role of ions and membrane potential in uptake of serotonin into plasma membrane vesicles from mouse brain. Biochem Pharmacol. 1989 Jul 1;38(13):2091–2097. [PubMed] [Google Scholar]
  • Cool DR, Leibach FH, Ganapathy V. Modulation of serotonin uptake kinetics by ions and ion gradients in human placental brush-border membrane vesicles. Biochemistry. 1990 Feb 20;29(7):1818–1822. [PubMed] [Google Scholar]
  • Liu Y, Peter D, Roghani A, Schuldiner S, Privé GG, Eisenberg D, Brecha N, Edwards RH. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell. 1992 Aug 21;70(4):539–551. [PubMed] [Google Scholar]
  • Fuller RW, Wong DT. Serotonin uptake and serotonin uptake inhibition. Ann N Y Acad Sci. 1990;600:68–80. [PubMed] [Google Scholar]
  • Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science. 1980 Jul 11;209(4453):303–305. [PubMed] [Google Scholar]
  • Stanley M, Virgilio J, Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science. 1982 Jun 18;216(4552):1337–1339. [PubMed] [Google Scholar]
  • Bastani B, Arora RC, Meltzer HY. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Biol Psychiatry. 1991 Jul 15;30(2):131–139. [PubMed] [Google Scholar]
  • Amara SG, Pacholczyk T. Sodium-dependent neurotransmitter reuptake systems. Curr Opin Neurobiol. 1991 Jun;1(1):84–90. [PubMed] [Google Scholar]
  • Cool DR, Leibach FH, Bhalla VK, Mahesh VB, Ganapathy V. Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J Biol Chem. 1991 Aug 25;266(24):15750–15757. [PubMed] [Google Scholar]
  • MacDonald RJ, Swift GH, Przybyla AE, Chirgwin JM. Isolation of RNA using guanidinium salts. Methods Enzymol. 1987;152:219–227. [PubMed] [Google Scholar]
  • Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. [PubMed] [Google Scholar]
  • Fremeau RT, Jr, Caron MG, Blakely RD. Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron. 1992 May;8(5):915–926. [PubMed] [Google Scholar]
  • Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989 Apr 15;77(1):61–68. [PubMed] [Google Scholar]
  • Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 1991 Mar 28;350(6316):350–354. [PubMed] [Google Scholar]
  • Blakely RD, Clark JA, Rudnick G, Amara SG. Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. Anal Biochem. 1991 May 1;194(2):302–308. [PubMed] [Google Scholar]
  • Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. [PubMed] [Google Scholar]
  • Yang-Feng TL, Floyd-Smith G, Nemer M, Drouin J, Francke U. The pronatriodilatin gene is located on the distal short arm of human chromosome 1 and on mouse chromosome 4. Am J Hum Genet. 1985 Nov;37(6):1117–1128.[PMC free article] [PubMed] [Google Scholar]
  • Boja JW, Patel A, Carroll FI, Rahman MA, Philip A, Lewin AH, Kopajtic TA, Kuhar MJ. [125I]RTI-55: a potent ligand for dopamine transporters. Eur J Pharmacol. 1991 Feb 26;194(1):133–134. [PubMed] [Google Scholar]
  • Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986 Jan 31;44(2):283–292. [PubMed] [Google Scholar]
  • Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. [PubMed] [Google Scholar]
  • von Heijne G. Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem. 1983 Jun 1;133(1):17–21. [PubMed] [Google Scholar]
  • Mayser W, Betz H, Schloss P. Isolation of cDNAs encoding a novel member of the neurotransmitter transporter gene family. FEBS Lett. 1991 Dec 16;295(1-3):203–206. [PubMed] [Google Scholar]
  • Ganapathy V, Kulanthaivel P, Tiruppathi C, Mahesh VB, Leibach FH. Inactivation of the human placental serotonin transporter by tyrosyl group-specific reagents. J Pharmacol Exp Ther. 1989 Oct;251(1):9–15. [PubMed] [Google Scholar]
  • Nelson H, Mandiyan S, Nelson N. Cloning of the human brain GABA transporter. FEBS Lett. 1990 Aug 20;269(1):181–184. [PubMed] [Google Scholar]
  • Myers CL, Lazo JS, Pitt BR. Translocation of protein kinase C is associated with inhibition of 5-HT uptake by cultured endothelial cells. Am J Physiol. 1989 Oct;257(4 Pt 1):L253–L258. [PubMed] [Google Scholar]
  • Kennelly PJ, Krebs EG. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J Biol Chem. 1991 Aug 25;266(24):15555–15558. [PubMed] [Google Scholar]
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta 30912-2100.
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta 30912-2100.
Copyright notice
Abstract
A Na(+)- and Cl(-)-coupled serotonin (5-hydroxytryptamine, 5HT) transporter is expressed on human neuronal, platelet, placental, and pulmonary membranes. The brain 5HT transporter appears to be a principal site of action of therapeutic antidepressants and may mediate behavioral and/or toxic effects of cocaine and amphetamines. Oligonucleotides derived from consensus transporter sequences were used to identify human placental cDNAs highly related to the rat brain 5HT carrier. Transfection of one of these cDNAs into HeLa cells yields a high-affinity (Km = 463 nM), Na(+)- and Cl(-)-dependent 5HT transport activity which can be blocked by selective 5HT transport inhibitors, including paroxetine, fluoxetine, and imipramine, and which is antagonized by cocaine and amphetamine. Sequence analysis reveals a 630-amino acid open reading frame bearing 92% identity to the cloned rat brain 5HT transporter, with identical predicted topological features and conserved sites for posttranslational modifications. Unlike the rodent, where a single mRNA appears to encode 5HT transporters, multiple hybridizing RNAs are observed in human placenta and lung. Somatic cell hybrid and in situ hybridization studies are consistent, however, with a single gene encoding the human 5HT transporter, localized to chromosome 17q11.1-17q12.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.